View Post

Antipsychotics Tied to Increased Breast Cancer Risk

In In The News by Barbara Jacoby

By: Batya Swift Yasgur, MA, LS From: medscape.com Use of antipsychotics that increase prolectin levels is significantly associated with an increased risk for breast cancer in women with schizophrenia, new research suggests. However, at least one expert says that at this point, clinical implications are premature. Investigators compared data from Finnish nationwide registers on more than 30,000 women diagnosed with …

View Post

Samsung Bioepis Announces Five-year Follow-up Results for ONTRUZANT® (trastuzumab) in Early or Locally Advanced HER2 Positive Breast Cancer

In Clinical Studies News by Barbara Jacoby

Source: Samsung Bioepis From: globenewswire.com Five-year follow-up results show comparable cardiac safety profile and long-term efficacy between biosimilar ONTRUZANT® (trastuzumab) and reference medicine HERCEPTIN® i (trastuzumab) in early or locally advanced HER2 positive breast cancer The longest monitoring data of patients treated with a trastuzumab biosimilar for HER2-positive early or locally advanced breast cancer Results presented at the European Society …

View Post

Challenges in the Multidisciplinary Management of Breast Cancer

In In The News by Barbara Jacoby

From: onclive.com Key opinion leaders highlight the challenges inherent in using multidisciplinary care to manage breast cancer, particularly when a patient is seen at multiple institutions. Joyce A. O’Shaughnessy, MD: A particular challenge is when patients are hospitalized. They oftentimes are at an outside institution, and you may not even know they’re hospitalized for a day or 2. Of course, …

View Post

AMEERA-1 and ER+/HER2- Metastatic Breast Cancer

In Clinical Studies News by Barbara Jacoby

By: Sarat Chandarlapaty, MD, PhD From: targetedonc.com Sarat Chandarlapaty, MD, offers his opinion on the potential roles amcenestrant could have in the treatment of ER+/HER2- metastatic breast cancer. Sarat Chandarlapaty, MD: The potential roles for amcenestrant could be a replacement of every place we use antiestrogen therapy in breast cancer. There’s potential for replacement of aromatase inhibitors, in the neoadjuvant …

View Post

Legislation may help identify breast cancer earlier in certain at-risk women

In In The News by Barbara Jacoby

By: Zachary Sweger From: psu.edu Laws designed to help women with increased risk for missed breast cancer diagnoses may help catch the disease earlier, according to Penn State College of Medicine researchers. They studied how notification and insurance coverage legislation for women with dense breast tissue affects the stage at which their cancer is diagnosed. More than 40% of women …

View Post

Savvy Cooperative: Adults (21+) who have been diagnosed with Acute Myeloid Leukemia or Stage 2 or 3 Lung Cancer

In Paid Opportunities For The Cancer Community by Barbara Jacoby

SCREENER SCOPE We’re looking for adults (21+) who have been diagnosed with Acute Myeloid Leukemia or Stage 2 or 3 Lung Cancer Eligibility Criteria: Adult (21+) who has been diagnosed with Acute Myeloid Leukemia or stage 2/3 lung cancer NOTE: Only patients with verified diagnoses will be considered US resident Details: Multiple Opportunities From home Receive: $75 – $100 Link: …

View Post

MacroGenics Announces Final Overall Survival Results from SOPHIA Study of MARGENZA™ in Patients with HER2-Positive Metastatic Breast Cancer

In Clinical Studies News by Barbara Jacoby

Source: MacroGenics From: pipelinereview.com Final overall survival (OS) analysis did not demonstrate a statistically significant advantage for MARGENZA over trastuzumab OS was greater with MARGENZA plus chemotherapy in exploratory subgroups of patients carrying a CD16A 158F allele compared to trastuzumab plus chemotherapy arm, while the OS for trastuzumab plus chemotherapy was greater than MARGENZA plus chemotherapy for the small exploratory …

View Post

Can Scalp Cooling Prevent Hair Loss?

In In The News by Barbara Jacoby

From: healthline.com By limiting blood flow to the scalp, cooling can protect your hair follicles from the effects of chemo drugs. Learn more about how it works and how much it costs. Scalp cooling is done by applying cold temperatures to your scalp during chemotherapy treatment for cancer. It’s sometimes called scalp hypothermia. Scalp cooling is intended to help prevent …

View Post

Ines Vaz-Luis, MD, PhD, on Risk Assessment in Premenopausal Hormone Receptor-Positive Breast Cancer

In Clinical Studies News by Barbara Jacoby

By: Jeff Minerd From: medpagetoday.com Online calculators, composite scores, and genetic assays can all inform treatment decisions Premenopausal women with hormone receptor-positive, early-stage breast cancer often present with more complex disease. They tend to require multimodality therapy and have inferior survival outcomes compared with postmenopausal women, noted Ines Vaz-Luis, MD, PhD, of Institut Gustave Roussy in Villejuif, France, and co-authors, …

View Post

What Is Cording?

In In The News by Barbara Jacoby

From: webmd.com Cording – also known as axillary web syndrome (AWS) – is a side effect of having lymph nodes removed as a result of breast cancer. A cord, or web of cords, develops under the skin on the inside of your arm. This rope-like tissue can be uncomfortable and make it difficult to use your arm normally, but there are …